keronyoga.blogg.se - Unfolder for the ar40e

Because the effective optical zone size is different for some of these IOLs, the incision size alone may not be the only relevant factor for optical outcome. Postimplantation incisions sizes of 2.96 to 3.74 mm were determined with 6-mm total optic foldable IOLs using Monarch and Unfolder injector systems. However, the relationship of incision size and effective IOL optical zone differed: AR40e (Unfolder Sapphire) < MA60BM < Clariflex < AR40e (Unfolder Emerald) < SA60AT with both Monarch II B and C cartridge (greater means better relationship). Combinations (2) and (4) were not statistically significantly different, but were statistically significantly smaller in preimplantation and postimplantation incision size compared with combination (1) and were larger compared with combinations (5) and (6). The incision sizes before and after implantation for (3) were significantly smaller than all other combinations. We measured incision width before and after phacoemulsification as well as before and after IOL implantation using a Kohnen caliper. With every combination, 25 IOLs were implanted. We performed implantation of foldable IOLs with sharp optic edges and 6-mm total optic diameter with their recommended injector systems and cartridges: (1) Alcon MA60BM with Monarch II/cartridge A, (2) Alcon SA60AT with Monarch II/cartridge B, (3) Alcon SA60AT with Monarch II/cartridge C, (4) AMO AR40e with Unfolder Sapphire, (5) AMO AR40e with Unfolder Emerald, and (6) AMO Clariflex with Unfolder Silver. One hundred fifty eyes of 150 patients with cataract and without other anterior segment pathological features or previous eye surgeries. Nonrandomized, prospective clinical study.

125000001424 substituent group Chemical group 0.To determine incision sizes for 6-mm optic foldable intraocular lenses (IOLs) implanted with injector systems.

238000006460 hydrolysis reaction Methods 0.000 claims abstract description 10.

239000011796 hollow space material Substances 0.000 claims abstract description 16.

230000002708 enhancing Effects 0.000 claims abstract description 73.

238000003780 insertion Methods 0.000 title claims abstract description 29.

Status Active legal-status Critical Current Anticipated expiration legal-status Critical Links CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). reassignment Johnson & Johnson Surgical Vision, Inc. Application granted granted Critical Publication of US9421091B2 publication Critical patent/US9421091B2/en Assigned to Johnson & Johnson Surgical Vision, Inc. Assignors: MAKKER, HARISH, HU, CAN B., LOWERY, MICHAEL D. With the rise in the general interest in wearable gadgets, the market has seen a huge rise in demand. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Technology and smart devices are products that evolve each day.

Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to US10/608,875 priority Critical patent/US20040267359A1/en Priority to US11/146,983 priority patent/US7687097B2/en Priority to US12/622,554 priority patent/US8956684B2/en Application filed by Abbott Medical Optics Inc filed Critical Abbott Medical Optics Inc Priority to US14/623,347 priority patent/US9421091B2/en Publication of US20150157454A1 publication Critical patent/US20150157454A1/en Assigned to Abbott Medical Optics Inc.

Original Assignee Abbott Medical Optics Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Lowery Current Assignee (The listed assignees may be inaccurate.

Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Granted Application number US14/623,347 Other versions US9421091B2 US20150157454A1 - IOL Insertion Apparatus